The two companies have teamed up to develop an innovative digital B2C solution for BNP Paribas Cardif's flagship product Mortgage Payment Protection Insurance (MPPI).
Subscribing to an MPPI can be complex – particularly due to the medical requirements – so it was essential for BNP Paribas Cardif in Belgium to simplify the process, ensuring a smooth and efficient experience for its partners and end users. With this in mind, the two companies have completely reviewed and redesigned the MPPI online flow.
Qover is supported by C. Entrepreneurs venture capital fund, created by BNP Paribas Cardif along withCathay Innovation.
Jean-Michel Hermange, Chief Strategy and Digital Officer at BNP Paribas Cardif in Belgium, commented on this collaboration:
'By partnering with Qover, we were able to benefit from both their technical knowledge and digital insurance expertise. They developed a solution for us in record time, and also helped us simplify processes such as signature and medical acceptance. We look forward to exploring other projects together.'
.png)
From a customer point of view, it's simple and easy: the user accesses a BNP Paribas Cardif website where they can subscribe to the insurance product by answering the specified questions and receiving their personalised rate. The signature process is also fully digitalised and the frontend website is accessible without the intermediary of a broker.
This digital solution can be integrated by any of BNP Paribas Cardif's partners using open API technology. The first partner to launch is the online bank Keytrade Bank which offers MPPI via this solution.
Quentin Colmant, CEO and Co-founder of Qover stated:
'We are thrilled to be the partner of choice for the digitalisation of one of BNP Paribas Cardif's flagship products in Belgium. A collaboration such as this one – between a scale-up and a major historical player – is a step in the right direction toward a world in full digital transformation. At Qover, we aspire to create real value for our partners; speed and flexibility are part of our DNA.'
